GSK and Hansoh’s ADC clinches late-stage win, teeing up regulatory submission in China
BioSpace
GSK and Hansoh Pharmaceutical's antibody-drug conjugate success validates their partnership, one of the many deals in which Big Pharma has tapped a China company for promising cancer candidates.
pharminent
July 10, 2026 (Last updated: July 15, 2026)
BioSpace
GSK and Hansoh Pharmaceutical’s antibody-drug conjugate success validates their partnership, one of the many deals in which Big Pharma has tapped a China company for promising cancer candidates.
